Biogen (BIIB) Return on Equity [ROE] (2009 - 2026)
Biogen's Return on Equity [ROE] came in at 4.45% for Q2 2026, down 4.39 percentage points from 8.84% a year earlier and down 2.98 percentage points from the prior quarter.
Powered by 
Analysis
Biogen (BIIB) Return on Equity [ROE] (2009 - 2026) Analysis & Trends
For FY2025, Biogen's Return on Equity [ROE] was 7.39%, down 2.96 percentage points from FY2024.
- Return on Equity [ROE] carries a five-year change of -26.41 percentage points (FY2020 to FY2025).
- Going back by year, Return on Equity [ROE] was 10.36% in FY2024 (+2.12 pp), 8.24% in FY2023 (-16.09 pp), 24.33% in FY2022 (+8.36 pp) and 15.96% in FY2021 (-17.84 pp).
- The Q2 2026 figure represents the lowest quarterly Return on Equity [ROE] in data going back to Q3 2009.
- Year-over-year, Return on Equity [ROE] has declined for four consecutive quarters, with an average year-over-year change of -0.66 percentage points over the last eight quarters.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in Q1 2023 (a gain of 9.14 percentage points), and the weakest in Q3 2021 (a drop of 27.62 percentage points).
- Business Quant data shows BIIB's Return on Equity [ROE] at 7.43% (Q1 2026), 7.09% (Q4 2025) and 8.98% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | - |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 31.52% |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 4.97% |
| 10 | Biogen | 37.51 Bn | 24.16 Bn | 1.96 Bn | 4.45% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.45% |
| Mar 31, 2026 | 7.43% |
| Dec 31, 2025 | 7.09% |
| Sep 30, 2025 | 8.98% |
| Jun 30, 2025 | 8.84% |
| Mar 31, 2025 | 8.78% |
| Dec 31, 2024 | 9.87% |
| Sep 30, 2024 | 10.01% |
| Jun 30, 2024 | 7.44% |
| Mar 31, 2024 | 7.78% |
| Dec 31, 2023 | 7.93% |
| Sep 30, 2023 | 10.10% |
| Jun 30, 2023 | 18.87% |
| Mar 31, 2023 | 23.04% |
| Dec 31, 2022 | 22.65% |
| Sep 30, 2022 | 19.42% |
| Jun 30, 2022 | 13.64% |
| Mar 31, 2022 | 13.90% |
| Dec 31, 2021 | 15.82% |
| Sep 30, 2021 | 19.06% |
API Access
Biogen Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=BIIB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "BIIB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=BIIB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();